Boston Globe - NEW YORK — An HSBC analyst upgraded Sanofi- Aventis SA Wednesday, citing the French drug maker’s full pipeline and shrugging off its failure to receive U.S. approval for the weight-loss drug Acomplia. In late June, Sanofi-Aventis withdrew its
Source: www.boston.com

Weight Loss Drug Linked to Suicide Risk
FOX News - The European Medicines Agency (EMEA) said this week a stronger warning is needed on the weightloss drug Acomplia (rimonabant) from sanofi-aventis, which has been linked to an increased suicide risk. The EMEA said it is especially important the people
Source: www.foxnews.com

Soy protein hydrolysate shows promise for weight management
Nutra Ingredients USA - The research, published in the journal Metabolism , could tap into the burgeoning weight loss and management market, estimated to already be worth $7bn ( 5.2bn) globally. It also has implications for diabetes. With 50 per cent of Europeans and 62 per
Source: www.nutraingredients-usa.com

Terra Daily - The traditional prescriptions for a healthy life-sensible diet, exercise and weight control-extend life by reducing signaling through a specific pathway in the brain, according to Howard Hughes Medical Institute researchers who discovered the

Science Daily - Science Daily There are no high quality data to assess how well dietary treatments for type 2 diabetes work in people who have just been told they have the disease, but there is evidence that taking on exercise seems to be one way of improving
Source: www.sciencedaily.com